Indivior PLC Ordinary Shares (INDV) had the highest return between September 22, 2022 and October 30, 2022 by a small-cap US stock, returning 492.8%.
| ASSET | DATE | % RETURN |
|---|---|---|
Indivior PLC Ordinary Shares (INDV) | 9/22/2022 - 10/30/2022 | 492.84% |
Biohaven Pharmaceutical (BHVN) | 9/22/2022 - 10/30/2022 | 155.5% |
Tango Therapeutics (TNGX) | 9/22/2022 - 10/30/2022 | 133.81% |
Prothena (PRTA) | 9/22/2022 - 10/30/2022 | 101.16% |
Spyre Therapeutics (SYRE) | 9/22/2022 - 10/30/2022 | 94.5% |
Enliven Therapeutics (ELVN) | 9/22/2022 - 10/30/2022 | 89.78% |
Vigil Neuroscience (VIGL) | 9/22/2022 - 10/30/2022 | 88.12% |
SS Innovations International Inc Common Stock (SSII) | 9/22/2022 - 10/30/2022 | 84.09% |
ADEIA (ADEA) | 9/22/2022 - 10/30/2022 | 63.87% |
89bio (ETNB) | 9/22/2022 - 10/30/2022 | 61.85% |
Next Technology (NXTT) | 9/22/2022 - 10/30/2022 | 57.75% |
American Public Education (APEI) | 9/22/2022 - 10/30/2022 | 55.5% |
Pacific Biosciences of California (PACB) | 9/22/2022 - 10/30/2022 | 54.06% |
Rocket Pharmaceuticals (RCKT) | 9/22/2022 - 10/30/2022 | 52.25% |
Helix Energy Solutions (HLX) | 9/22/2022 - 10/30/2022 | 50.46% |
Harrow Health (HROW) | 9/22/2022 - 10/30/2022 | 46.71% |
Nabors Industries (NBR) | 9/22/2022 - 10/30/2022 | 45.95% |
Expro (XPRO) | 9/22/2022 - 10/30/2022 | 45.75% |
Autolus Therapeutics (AUTL) | 9/22/2022 - 10/30/2022 | 44.23% |
Keros Therapeutics (KROS) | 9/22/2022 - 10/30/2022 | 43.98% |
Ideaya Biosciences (IDYA) | 9/22/2022 - 10/30/2022 | 40.85% |
Pulse Biosciences (PLSE) | 9/22/2022 - 10/30/2022 | 40% |
Aehr Test Systems (AEHR) | 9/22/2022 - 10/30/2022 | 39.53% |
Par Pacific (PARR) | 9/22/2022 - 10/30/2022 | 38.55% |
Riley Exploration Permian (REPX) | 9/22/2022 - 10/30/2022 | 37.44% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
